Simona Zipursky

Suggest Changes
Learn More
BACKGROUND In October 2012, the Meningococcal A conjugate vaccine MenAfriVac was granted a label variation to allow for its use in a controlled temperature chain (CTC), at temperatures of up to 40°C(More)
  • 1